The COVID-19 pandemic necessitated transition of care to telemedicine due to public health concerns. Those with LBD represent a particularly vulnerable population to the complications of COVID-19 given advanced age and the clinical features inherent to LBD. While the call for telemedicine during COVID-19 is clear, it is less clear how in-office diagnosis and care translates to virtual care in this population. The Lewy Body Dementia Association (LBDA), the Research Center of Excellence (RCOE) program, and the ISTAART DLB Professional Interest Area Executive Committee have, therefore, collectively identified a need for a series of webinars that address the topic of virtual care in LBD during the COVID-19 pandemic and beyond.
Webinar #1: The approach to clinical care via telemedicine
Faculty Bios
Access the slides
Review the FAQs
Watch recording from March 4, 2021
Webinar #2: Understanding Current Research on Virtual Assessment
Date: April 8, 2021
Time: 9am EST/ 2pm UTC
Faculty Bios
Access the slides
Review the FAQs
Watch recording from April 8, 2021
Webinar #3: Impact of COVID-19 in those with LBD
Date: May 27, 2021
Time: 10am EST/3pm UTC
Faculty Bios
Access the Slides
Review the FAQs
Watch recording from May 27, 2021
Target Audience
This activity has been designed to meet the educational needs of healthcare providers involved in the care of patients with Lewy body dementia.
Course Directors
Katherine Amodeo, MD
Department of Neurology
Westchester Medical Center
Poughkeepsie, NY
Jennifer Goldman, MD, MS
Shirley Ryan Ability Lab, Parkinson’s Disease and Movement Disorders
Northwestern University Feinberg School of Medicine
Chicago, IL
Jointly provided by Postgraduate Institute of Medicine and Lewy Body Dementia Association
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and the Lewy Body Dementia Association. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 credit™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.
Allied healthcare professionals Participants will receive a Certificate of Attendance stating this program is designated for 1.0 AMA PRA Category 1 Credit™. This credit is accepted by the AANP and the AAPA.
American Board of Psychiatry and Neurology Approval ABPN diplomates who need to fulfill their MOC needs, the webinars are approved CME products. Each activity awards up to 1 Category 1 CME credits toward your MOC folio.
There is no fee to attend. This activity is supported through an educational grant from Acadia Pharmaceuticals Inc.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.